Lung transplantation in cystic fibrosis normalizes essential fatty acid profiles

Journal of Cystic Fibrosis

Volumn 12, Issue 3, 2013, Pages 222-228

  Witters, Peter ^a,b   Dupont, Lieven ^a   Vermeulen, François ^a   Proesmans, Marijke ^a   Cassiman, David ^b   Wallemacq, Pierre ^c   De Boeck, Kris ^a  

^a UNIVERSITY HOSPITALS LEUVEN   (Belgium)

^b UNIVERSITY OF LEUVEN   (Belgium)

^c CLINIQUES UNIVERSITAIRES SAINT LUC   (Belgium)

Author keywords

Cystic fibrosis; Essential fatty acid; Lung transplantation; Poly unsaturated fatty acid

Indexed keywords

5,8,11 ICOSATRIENOIC ACID; ARACHIDIC ACID; ARACHIDONIC ACID; BEHENIC ACID; DIHOMO GAMMA LINOLENIC ACID; DOCOSAHEXAENOIC ACID; ERUCIC ACID; ESSENTIAL FATTY ACID; GAMMA LINOLENIC ACID; LAURIC ACID; LIGNOCERIC ACID; LINOLEIC ACID; LINOLENIC ACID; MYRISTIC ACID; OLEIC ACID; PALMITIC ACID; PALMITOLEIC ACID; STEARIC ACID; VACCENIC ACID;

ADULT; ARTICLE; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; CYSTIC FIBROSIS; FEMALE; HUMAN; LIPID ANALYSIS; LIPID BLOOD LEVEL; LUNG TRANSPLANTATION; MALE;

ADULT; CYSTIC FIBROSIS; FATTY ACIDS, ESSENTIAL; FEMALE; HUMANS; LUNG TRANSPLANTATION; MALE;

EID: 84877000286     PISSN: 15691993     EISSN: 18735010     Source Type: Journal    
DOI: 10.1016/j.jcf.2012.09.004     Document Type: Article

References (22)

1. Coste T.C., Armand M., Lebacq J., Lebecque P., Wallemacq P., Leal T. An overview of monitoring and supplementation of omega 3 fatty acids in cystic fibrosis. Clin Biochem 2007, 40:11-520.
2. Kuo P.T., Huang N.N., Bassett D.R. The fatty acid composition of the serum chylomicrons and adipose tissue of children with cystic fibrosis of the pancreas. J Pediatr 1962, 60:394-403.
3. Lloyd-Still J.D., Bibus D.M., Powers C.A., Johnson S.B., Holman R.T. Essential fatty acid deficiency and predisposition to lung disease in cystic fibrosis. Acta Paediatr 1996, 85:1426-1432.
4. Beharry S., Ackerley C., Corey M., Kent G., Heng Y.M., Christensen H., et al. Long-term docosahexaenoic acid therapy in a congenic murine model of cystic fibrosis. Am J Physiol Gastrointest Liver Physiol 2007, 292:G839-G848.
5. Freedman S.D., Katz M.H., Parker E.M., Laposata M., Urman M.Y., Alvarez J.G. A membrane lipid imbalance plays a role in the phenotypic expression of cystic fibrosis in cftr(-/-) mice. Proc Natl Acad Sci U S A 1999, 96:13995-14000.
6. Carlstedt-Duke J., Brönnegård M., Strandvik B. Pathological regulation of arachidonic acid release in cystic fibrosis: the putative basic defect. Proc Natl Acad Sci U S A 1986, 83:9202-9206.
7. Freedman S.D., Blanco P.G., Zaman M.M., Shea J.C., Ollero M., Hopper I.K., et al. Association of cystic fibrosis with abnormalities in fatty acid metabolism. N Engl J Med 2004, 350:560-569.
8. Lloyd-Still J.D., Johnson S.B., Holman R.T. Essential fatty acid status in cystic fibrosis and the effects of safflower oil supplementation. Am J Clin Nutr 1981, 34:1-7.
9. Farrell P.M., Mischler E.H., Engle M.J., Brown D.J., Lau S.M. Fatty acid abnormalities in cystic fibrosis. Pediatr Res 1985, 19:104-109.
10. Hubbard V.S., Dunn G.D., di Sant'Agnese P.A. Abnormal fatty-acid composition of plasma-lipids in cystic fibrosis. A primary or a secondary defect?. Lancet 1977, 2:1302-1304.
11. Roulet M., Frascarolo P., Rappaz I., Pilet M. Essential fatty acid deficiency in well nourished young cystic fibrosis patients. Eur J Pediatr 1997, 156:952-956.
12. Strandvik B., Gronowitz E., Enlund F., Martinsson T., Wahlström J. Essential fatty acid deficiency in relation to genotype in patients with cystic fibrosis. J Pediatr 2001, 139:650-655.
13. Christophe A.B., Warwick W.J., Holman R.T. Serum fatty acid profiles in cystic fibrosis patients and their parents. Lipids 1994, 29:569-575.
14. Maqbool A., Schall J.I., Garcia-Espana J.F., Zemel B.S., Strandvik B., Stallings V.A. Serum linoleic acid status as a clinical indicator of essential fatty acid status in children with cystic fibrosis. J Pediatr Gastroenterol Nutr 2008, 47:635-644.
15. Döring G., Conway S.P., Heijerman H.G., Hodson M.E., Høiby N., Smyth A., et al. Antibiotic therapy against pseudomonas aeruginosa in cystic fibrosis: a European consensus. Eur Respir J 2000, 16:749-767.
16. Coste T.C., Deumer G., Reychler G., Lebecque P., Wallemacq P., Leal T. Influence of pancreatic status and sex on polyunsaturated fatty acid profiles in cystic fibrosis. Clin Chem 2008, 54:388-395.
17. Andersson C., Al-Turkmani M.R., Savaille J.E., Alturkmani R., Katrangi W., Cluette-Brown J.E., et al. Cell culture models demonstrate that CFTR dysfunction leads to defective fatty acid composition and metabolism. J Lipid Res 2008, 49:1692-1700.
18. Landon C., Kerner J.A., Castillo R., Adams L., Whalen R., Lewiston N.J. Oral correction of essential fatty acid deficiency in cystic fibrosis. JPEN J Parenter Enter Nutr 1981, 5:501-504.
19. Rogiers V., Dab I., Michotte Y., Vercruysse A., Crokaert R., Vis H.L. Abnormal fatty acid turnover in the phospholipids of the red blood cell membranes of cystic fibrosis patients (in vitro study). Pediatr Res 1984, 18:704-709.
20. Strandvik B., Svensson E., Seyberth H.W. Prostanoid biosynthesis in patients with cystic fibrosis. Prostaglandins Leukot Essent Fatty Acids 1996, 55:419-425.
21. Gilljam H., Strandvik B., Ellin A., Wiman L.G. Increased mole fraction of arachidonic acid in bronchial phospholipids in patients with cystic fibrosis. Scand J Clin Lab Invest 1986, 46:511-518.
22. Christophe A., Robberecht E. Current knowledge on fatty acids in cystic fibrosis. Prostaglandins Leukot Essent Fatty Acids 1996, 55:129-138.